Anzeige
Meldung des Tages: Vor der Neubewertung dank Dealfantasie? Dieser Explorer bringt sich jetzt strategisch in Position

Actinium Pharmaceuticals News

Aktie
WKN:  A2QA48 ISIN:  US00507W2061 US-Symbol:  ATNM Branche:  Biotechnologie Land:  USA
1,256 €
+0,03 €
+2,45%
10:49:07 Uhr
Depot/Watchlist
Marktkapitalisierung *
40,29 Mio. €
Streubesitz
77,78%
KGV
-1,31
Index-Zuordnung
-

Actinium Pharmaceuticals News

28.04.25 - PR Newswire
Actinium Highlights Mutation Agnostic Antileukemic Activity of Actimab-A Against FLT3, NPM1, KMT2A and TP53 Mutations in AML Models Demonstrating Backbone Potential for Acute Myeloid Leukemia Treatment at the American Association for Cancer Research Annual Meeting
Actinium Highlights Mutation Agnostic Antileukemic Activity of Actimab-A Against FLT3, NPM1, KMT2A and TP53 Mutations in AML Models Demonstrating Backbone Potential for Acute ...
28.04.25 - PR Newswire
May 27, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against ATNM
May 27, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against ATNM PR Newswire
25.04.25 - PR Newswire
Class Action Filed Against Actinium Pharmaceuticals, Inc. (ATNM) Seeking Recovery for Investors - Contact Levi & Korsinsky
Class Action Filed Against Actinium Pharmaceuticals, Inc. (ATNM) Seeking Recovery for Investors - Contact Levi & Korsinsky PR Newswire
24.04.25 - PR Newswire
Shareholders that lost money on Actinium Pharmaceuticals, Inc.(ATNM) should contact The Gross Law Firm about pending Class Action - ATNM
Shareholders that lost money on Actinium Pharmaceuticals, Inc.(ATNM) should contact The Gross Law Firm about pending Class Action - ATNM PR Newswire
23.04.25 - PR Newswire
ATNM Investors Have Opportunity to Lead Actinium Pharmaceuticals, Inc. Securities Fraud Lawsuit
ATNM Investors Have Opportunity to Lead Actinium Pharmaceuticals, Inc. Securities Fraud Lawsuit PR Newswire
22.04.25 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Actinium Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - ATNM
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Actinium Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - ...
22.04.25 - PR Newswire
Levi & Korsinsky Reminds Actinium Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 27, 2025 - ATNM
Levi & Korsinsky Reminds Actinium Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 27, 2025 - ATNM PR Newswire
21.04.25 - PR Newswire
Class Action Filed Against Actinium Pharmaceuticals, Inc. (ATNM) - May 27, 2025 Deadline to Join - Contact The Gross Law Firm
Class Action Filed Against Actinium Pharmaceuticals, Inc. (ATNM) - May 27, 2025 Deadline to Join - Contact The Gross Law Firm PR Newswire

Newssuche

Videos

newspaper
20.04.26 -1,10%
Technical Trading: GBP Long im Trend
GBP/USD Long Typ: Open End Turbo WKN: VV7A4S Hebel: 10 Laufzeit: OpenEnd Einstieg: Market ... Mehr »